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Introduction: Hemoptysis is observed frequently in patients, although chest computed tomog-
raphy (CT) shows no explainable lesion as the cause of hemoptysis. However, the clinical
course of these patients has not been reported fully.
Methods: This study included patients who visited Seoul National University Hospital and Seoul
National University Bundang Hospital to be treated for hemoptysis from January 2003 through
October 2009 and who had no lesion causing hemoptysis in chest CT. We retrospectively
analyzed their bronchoscopic and clinical findings.
Results: A total of 228 patients were included, and the mean follow-up duration was 781 days.
All patients underwent bronchoscopy. The bronchoscopic findings of 191 patients (83.8%) were
negative for hemoptysis and showed the possible causes of bleeding in 37 patients (16.2%).
Forty-three of the 191 patients with negative bronchoscopic findings had oronasopharyngeal
problems or were using anticoagulants. After excluding these 43 patients, hemoptysis recurred
in 29 (19.6%) of the remaining patients. Thirteen of the patients whose bronchoscopic findings
identified the possible causes of bleeding (35.1%) experienced recurrence. Only one patient
(0.4%) was diagnosed with lung cancer by the initial bronchoscopy, and no patient developed
malignancy during the follow-up period.phy; SD, standard deviation.
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414 Y.J. Lee et al.Conclusion: The recurrence rate was higher in the patients with positive findings than in the
patients with negative findings on bronchoscopy. Although about 20% of patients with negative
bronchoscopy findings experienced recurrence, the clinical course of those in whom recurrent
bleeding occurred was usually benign.
ª 2011 Elsevier Ltd. All rights reserved.Introduction
Hemoptysis is a common and important symptom in clinical
practice and accounts for 10e15% of all pulmonary consul-
tations. Hemoptysis can range from blood streaking of
sputum to gross blood without any accompanying sputum.
The symptoms are distressing for the patient and frequently
raise concern about serious underlying disorders, including
lung cancer.1 Therefore, a thorough evaluation of a patient
with even a small amount of hemoptysis is important.
Diagnosing the cause of hemoptysis is often difficult,more
so in patients presenting with a normal or nonlocalizing chest
radiograph. In 1985, Adelman et al. referred to a condition
called ‘cryptogenic hemoptysis,’ which was defined as no
clear cause of bleeding despite a thorough evaluation.2 They
estimated that this occurs in about 30% of all hemoptysis
patients and suggested that this condition is related most
often to acute or chronic bronchial inflammation, occult
bronchiectasis, inactive tuberculosis, pulmonary vascular
abnormalities, and coagulation abnormalities.2
A Korean study reported the clinical outcomes of
hemoptysis patients with normal chest radiographs in
1993.3 Initial bronchoscopy was performed in all patients
and produced a diagnosis in 10% (8/80) of patients. Among
the remaining 72 patients, chest computed tomography
(CT) or bronchography was performed to evaluate the
cause of hemoptysis. However, only 22% (16/72) of patients
had a chest CT because CT was not readily available at that
time. The causes of hemoptysis in this study were listed as
endobronchial cancer, chronic bronchitis, endobronchial
tuberculosis, bronchiectasis, and catamenial hemoptysis.3
CT and bronchoscopy are now widely accepted in the
screening of hemoptysis patients with normal chest radio-
graphs. The technology and resolution power have
improved markedly. Magu and colleagues reported that
a chest CT provided diagnostic information in 16 (53%) of 30
patients with normal chest radiographs.4 Other authors
have reported abnormalities in 39e60% of cases.5e7
Many studies have suggested that CT and bronchoscopy
are complementary methods, and have recommended that
both tests are used in hemoptysis patients with a non-
localizing chest radiograph. However, there has been little
research on the clinical course of patients whose chest CT
does not show an obvious cause of hemoptysis.Most articles
included patients with hemoptysis whose simple radiographs
were normal, but did not focus on patients with a normal CT.
However, in clinical practice, a chest CT cannot identify
a lesion as the cause of hemoptysis in some patients, and it
can be difficult to manage these patients and to explain the
clinical course and prognosis of their symptoms.
The aim of this study was to describe the clinical course
and long-term outcomes of patients with hemoptysis whose
chest CT shows no lesion to explain the hemoptysis.Methods
This study included patients who visited Seoul National
University Hospital and Bundang Seoul National University
Hospital from January 2003 through October 2009. The
included patients had a chief complaint of subjective
hemoptysis or blood-tinged sputum but had no explainable
lesions for hemoptysis on chest CT. The results of the chest
CT were reported by a radiologist.
We retrospectively reviewed the medical records, chest
CT, and bronchoscopy findings of the patients. From the
medical records, the following clinical variables were
collected: age, sex, smoking history, comorbidities, dura-
tion of follow-up, recurrence of hemoptysis, newly devel-
oped significant findings during the follow-up period, and
the final diagnosis based on clinical, radiological, and
histological findings. All patients underwent bronchoscopic
evaluations by the pulmonology doctors in the fellowship
under the supervision of senior professors. In cases without
evidence of bleeding in bronchoscopy, the patients visited
an otolaryngologist or dentist, and some were examined by
esophagogastroduodenoscopy to exclude intraoral or naso-
pharyngeal bleeding. This retrospective data collection was
approved by the institutional review board of Seoul
National University (IRB No: H-0904-048-278) and has
therefore been performed in accordance with the Decla-
ration of Helsinki.
The Statistical Package for the Social Sciences (SPSS)
version 10.0 (SPSS Corporation, Chicago, IL) was used for
statistical analysis. The patients’ clinical variables were
expressed as mean standard deviation (SD) and range. We
compared the clinical variables between the recurrence
group and nonrecurrence group using Student’s t test and
the c2 test. Logistic regression was used for multivariate
analysis.
Results
Clinical features
Two hundred and twenty-eight patients, whose mean age
was 51.6 years, were included in this study; about 56% of
these patients had never smoked (nZ 129), and 26 (11.4%)
had been treated adequately for pulmonary tuberculosis
previously. The baseline characteristics and comorbidities
of the patients are listed in Table 1.
CT findings
The chest CT findings of these patients were normal (36.0%)
or included granulomas or tiny nodules (32.9%), ground
glass opacity (16.7%), linear atelectasis (15.8%), small
Table 1 Baseline characteristics of the study population.
N (%)
Total population, n 228
Male, n (%) 120 (52.6)
Age, yr (mean SD) 51.6 14.9
Smoking history
Nonsmoker 129 (56.6)
Current smoker 54 (23.7)
Ex-smoker 34 (19.7)
Body mass index, kg/m2 (mean SD) 23.6 4.3
Comorbidity, n (%)
Hypertension 62 (27.2)
History of tuberculosis 26 (11.4)
Diabetes mellitus 25 (11.0)
Dyslipidemia 24 (10.5)
Malignancy 20 (8.8)
Chronic liver disease 19 (8.3)
Hypothyroidism 8 (3.5)
Ischemic heart disease 8 (3.5)
Stroke 6 (2.2)
Hyperthyroidism 4 (1.8)
Atrial fibrillation 3 (1.3)
Follow-up duration, days, mean SD 780.4 737.2
Embolization, n (%) 11 (2.8)
Table 3 Bronchoscopic findings in the study population.
Bronchoscopic findings N (%)
Negative for possible causes of
hemoptysis
191 (83.8)
Normal 158 (82.7)
Blood clot 20 (10.5)
Thick secretion 8 (4.2)
Bronchus narrowing with fibrosis 3 (1.6)
Dynamic compression of bronchus 2 (1.0)
Positive for possible causes of hemoptysis 37 (16.2)
Anthracofibrosis 14 (37.8)
Bronchial inflammation 9 (24.3)
Telangiectasia and prominent vessel 6 (16.2)
Elevated mucosal lesion a 4 (10.8)
Petechiae 2 (5.4)
Tracheobronchopathia
osteochondroplastica
1 (2.7)
Granulation tissue on previous
lobectomy site
1 (2.7)
a Elevated mucosal lesion observed in one patient who was
diagnosed with squamous cell lung cancer by bronchial washing
cytology.
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(8.8%). The CT findings are listed in Table 2.Bronchoscopic findings
Bronchoscopy was performed in all patients. We found the
possible cause of bleeding in 37 (16.2%) patients (positive
for possible causes of hemoptysis in Table 3) and the
bronchoscopic findings showed no cause of bleeding
(negative for possible causes of hemoptysis in Table 3) in
the other 191 patients (83.8%).
One of the patients who showed an elevated mucosal
lesion in bronchoscopy was diagnosed with squamous cell
lung cancer by bronchial washing cytology, and he received
an operation. The results of the biopsy or washing cytology
in the other three patients who showed an elevated
mucosal lesion indicated chronic inflammation.Table 2 Chest CT findings of the study population.
N (%)
Normal 82 (36.0)
Granuloma or tiny nodule 75 (32.9)
Ground-glass opacity 38 (16.7)
Linear atelectasis 36 (15.8)
Small lymph node enlargement 13 (5.7)
Othersa 20 (8.8)
a Emphysema (8), secretory material (5), cardiomegaly (3),
aneurysmal dilatation of the ascending aorta (2), and pleural
calcification (2).Clinical course of the patients
Thirty-seven patients in the group with positive findings on
bronchoscopy were followed for a mean duration of 768
days. Hemoptysis recurred in 35.1% patients, and the mean
duration for the first recurrence was 207 days (Table 4 and
Fig. 1). One of these patients developed a new nodule,
which was detected by chest CT one year after the first
visit; this was considered as an arteriovenous malforma-
tion, and the patient was free of recurrence.
The other 191 patients in the group with negative findings
on bronchoscopy visited an otolaryngologist (151 patients) or
dentist (175 patients), and some of them received an
esophagoduodenoscopy (88 patients) to exclude intraoral or
nasopharyngeal bleeding. Twenty-seven patients had sinus
or dental problems, and 20 patients were using antiplatelet
or anticoagulant agents. Among these patients, four had
both sinus problems andwere taking antiplatelet drugs. In
total, 43 patients were thought to have oropharyngeal
bleeding or anticoagulation effects.
One hundred and forty-eight patients (excluding the 43
patients from the group with negative findings on bron-
choscopy) were thought to have episodes of real hemop-
tysis. Among these patients, hemoptysis recurred in 19.6%
patients, and the mean time for recurrence was 410 days
(Table 4 and Fig. 1). During the follow-up period, pulmo-
nary tuberculosis developed in one patient without recur-
rence of hemoptysis. The final diagnosis of the cause of
hemoptysis was made in six patients, catamenial hemop-
tysis in five, and polyarteritisnodosa in one. Except for
these six patients, the causes for hemoptysis in the other
patients remained unknown, and no patients developed
a malignancy during the follow-up.
The time to the first recurrence of the symptom was
significantly shorter and the recurrence rate was significantly
higherin the group with positive findings than in the group
with negative findings on bronchoscopy (Table 4). In
Table 4 Follow-up results of the patients.
Positive bronchoscopic
cases (NZ 37)
Negative bronchoscopic cases
of real hemoptysis (NZ 148)
P-value
Male, % 15 (40.5%) 79 (53.4%) 0.162
Mean age (year) 52.8 17.8 49.9 14.3 0.292
Mean hemoglobin (g/dL) 13.7 1.6 14.0 1.4 0.172
Follow-up days (mean) 767.8 828.5 742.9 703.5 0.853
Recurrence rate 13 (35.1%) 29 (19.6%) 0.044
Mean days for recurrence
(mean)
206.6 164.9 409.8 470.1 0.046
New finding developed,
number of patients
1: Small nodule
e suggestive of
arteriovenous
malformation
1: Pulmonary tuberculosis 0.999
Final diagnosis was made
during the follow-up
period, number of
patients
0 6 0.996
5: Catamenial hemoptysis
1: Polyarteritis nodosa
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19.5% (95% CI, 0.09e0.41) in the group with positive findings
and 4% (95%CI, 0.01e0.99) in the groupwith negative findings
on bronchoscopy over a standard time interval (500 days).New findings or possible cause of 
hemoptysis appeared during follow-up
5: catamenial hemoptysis
1: polyarteritis nodosa
1: pulmonary tuberculosis
Rebleeding
29 (19.6%)
No bleeding
119 (80.4%)
148 patients
Mean follow-up 742.9 days
No focus of bleeding in Bronchoscopy
N = 191 (83.8%)
43 patients excluded
- Oronasopharyngeal 
problems
- Taking antiplatelets or 
anticoagulant drugs
Hemoptysis without focus of bleedin
Bronchoscopy (N
Figure 1 Follow-up results of patients with hemopAfter excluding the 43 patients who were thought not to
have real hemoptysis, we compared the clinical variables in
patients who experienced recurrence (nZ 42) and who did
not experience recurrence (nZ 143).New findings or possible cause of 
hemoptysis appeared during follow-up
1: small nodule
– Arteriovenous malformation
No bleeding
24(64.9%)Rebleeding
13 (35.1%)
37 patients
Mean follow-up 767.8 days
Possible cause of bleeding in 
Bronchoscopy
N = 37 (16.2%)
g in chest CT (N = 228)
 = 228)
tysis without an explainable lesion in chest CT.
Figure 2 KaplaneMeier curve of recurrence free rate in two
groups with positive and negative findings on bronchoscopy.
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recurrence group (1017.8 715.2 days vs. 668.6 714.7
days, PZ 0.006). The percentage of patients with new
findings or who received a final diagnosis of the cause of
hemoptysis during the follow-up period was significantly
higher in the recurrence group (11.9% vs. 2.1%, PZ 0.016)
and the differences in these two variables were remained
significant in the multivariate analysis.
Discussion
We tried to evaluate the clinical course of patients with
hemoptysis who did not show a demonstrable cause in their
chest CT. We found the possible cause of hemoptysis in
16.2% of the 228 patients using the initial bronchoscopy.
Forty-three patients were classified as having oropharyn-
geal bleeding or using anticoagulants after bronchoscopy,
visiting an otolaryngologist or dentist, and receiving an
esophagoduodenoscopy. During the follow-up period, the
final diagnosis of the cause of hemoptysis was made in six
patients (catamenial hemoptysis in five and PAN in one),
and new findings were detected in two patients (pulmonary
tuberculosis in one and a small nodule in the other). Among
the 228 patients with hemoptysis and no demonstrable
cause in chest CT, we could find the cause in 86 (37.7%)
patients, although it was not real hemoptysis in 43 patients.
The cause in the other 142 patients (62.3%) remained
unknown during the follow-up period.
In the study of Thirumaran et al,8 which included
patients with normal chest X-ray, the cause of hemoptysis
remained unexplained in 5.8% after CT and bronchoscopic
evaluation. Because we included patients who had already
been evaluated by CT the number of patients with an
unknown cause of hemoptysis was higher in our study than
in the study by Thirumaran et al. Nevertheless, in the
patients whose CT findings were negative, we could find the
cause in 37.7% through a careful history and full examina-
tion including bronchoscopy. We believe that in patients
with hemoptysis whose chest CT is negative for the cause of
hemoptysis, the history, physical examination, bronchos-
copy, and evaluation for upper oropharyngeal bleeding are
essential parts of the diagnostic work-up.In this study, the initial bronchoscopy gave a diagnosis in
16.2% of patients, and one (0.4%) of them was diagnosed
with lung cancer by bronchial washing cytology during the
initial episode of hemoptysis. Previous studies found
a 0e16% cancer detection rate for bronchoscopy in patients
with hemoptysis and normal chest radiograph.9e11 Kaminski
et al. 12 reported a cancer detection rate of up to 21% and
83% diagnostic value for nonspecific bronchitis and tuber-
culosis for a single bronchoscopy in patients with hemop-
tysis and normal chest radiograph. These studies included
patients whose chest radiographs were normal but did not
focus on a CT, and the diagnostic value of bronchoscopy
was higher than in our study, which included patients whose
chest CT was normal.
Herth et al.13 reported the clinical outcomes of patients
with hemoptysis of unknown etiology in a retrospective
study that included 722 patients with hemoptysis. One
hundred and thirty-five patients (19%) had hemoptysis of
unknown origin. These 135 patients were observed for
a mean of 6.6 years, and lung cancer developed in 6% during
the follow-up period.
In our study, the overall mean follow-up period was 751
days (2.1 years), and no patients developed lung cancer
during the follow-up period. In contrast to the study by Herth
et al., the relatively short follow-upduration in our studymay
be the reason for the low detection rate of malignancy (2.1
years vs. 6.6 years). However, in the study by Herth et al., an
initial chest CT was not performed in all patients as in our
study, and the chest CTwas obtained at the discretion of the
evaluating pulmonary physician,13 suggesting the possibility
that cases of lung cancer were not detected during the initial
episode of hemoptysis. This is supported by the finding that
seven cases of lung cancer were detected at an unresectable
stage at the time of diagnosis.
Hemoptysis of unknown origin is usually diagnosed when
no clear cause of bleeding is evident despite thorough
evaluation.2 In previous studies, these cases accounted for
7e25% of hemoptysis cases2,6,13 and the clinical course was
usually minor and benign.2,14 Adelman et al.2 evaluated the
clinical outcomes of 67 patients with hemoptysis and non-
localizing chest roentgenogram and nondiagnostic bron-
choscopy examination. During a 38 22 (SD)-month period
(3.1 1.8 years), 85% of patients remained well without
evidence of active tuberculosis or malignancy. One patient
(1.4%) developed bronchogenic carcinoma 20 months after
bronchoscopy, and hemoptysis recurred in eight patients
(11.9%).
More recently, in 2007 Savale et al.15 prospectively
studied the clinical course of 73 patients with cryptogenic
hemoptysis after performing X-ray, bronchoscopy, and a CT
scan. The mean follow-up duration was 3.9 (2.9) years. No
cancer developed, and hemoptysis recurred in only 10
patients (13.7%). In our study, the overall recurrence rate
was about 20%, which is slightly higher than that in the
study by Savale et al. We speculate that differences in the
included patients and treatment strategies might explain
the differences in results between their study and ours. The
study by Savale et al. included only patients admitted to
a respiratory intermediate care ward and intensive care
unit. Initial bronchial arterial embolization was performed
in 53% of patients to control bleeding. In other words, there
were more patients with severe hemoptysis in the study by
418 Y.J. Lee et al.Savale et al. and this bleeding required active control. By
contrast, only 11 patients (4.8%) underwent embolization
during the initial episode of hemoptysis in our study. Most
patients experienced light symptoms and had no need for
active invasive treatment. Consistent with the studies
mentioned above, no patients developed a malignancy
during the follow-up in our study despite the 20% recur-
rence rate, even in negative bronchoscopy patients. We
speculate that the clinical presentation of hemoptysis
without demonstrable cause in a full examination including
chest CT and bronchoscopy usually comprises minor to
chronic bleeding with a benign course.
A 1993 Korean study3 showed that bronchiectasis,
endobronchial or pulmonary tuberculosis, bronchogenic
carcinoma or metastatic cancer in the bronchus, and
catamenial hemoptysis are major causes of hemoptysis in
patients with a negative chest radiograph. Because our
study included patients with negative CT findings, these
causes (infection, lung cancer, and bronchiectasis), which
are easily detected by chest CT, were excluded initially.
Thus, the causes of hemoptysis that we detected differed
considerably from those in previous studies; endobronchial
carcinoma, small minor abnormalities in the bronchus that
are not detected easily by CT.
In our study, the follow-up duration was significantly
longer in the recurrence group than in the nonrecurrence
group. The number of cases for which the final diagnosis was
made during the follow-up was significantly higher in the
recurrence group. These findings suggest that the higher the
frequency of hemoptysis, the more willing patients are to
visit the doctors and attend regular follow-up, meaning that
the diagnosis or new findings will be discovered in more
patients during the follow-up period. We think that the
recurrence of symptoms should alert the physician to the
possibility of undetected potential pathological findings.
This study has several limitations. First, we could not get
the exact amount of hemoptysis of all the patients from the
chart review. This is the limitation of this retrospective
design. However, most patients in this study experienced
several episodes of blood-tinged sputum and were followed
up in the outpatient clinic. Only a small portion of patients
(4.8%) had massive hemoptysis and they received emboli-
zation for the control of bleeding. From the available data
records, we found that the roughly estimated amount of
hemoptysis was 7.9 cc (12.4).
Second, we did not include all patients with hemoptysis
visiting our hospitals. We included only the patients with
hemoptysis who had both chest CT and bronchoscopy. In
clinical practice in our hospital, we usually perform
a screening chest CT scan for patients with hemoptysis,
especially when there is no definite abnormality in simple
chest X-ray. When there is a definite lesion in simple chest
X-ray which could be a cause of hemoptysis such as bron-
chiectasis or tuberculosis, chest CT scan is performed case
by case. Actually there were 26 patients with hemoptysis
who did not undergo chest CT scan during the study time
interval.This can be a selection bias in this study. Third, it
was too difficult to make sure that excluded 43 patients did
not have real hemoptysis. However, they had no evidence
of bleeding focus in both bronchoscopy and chest CT
initially and 36 patients (83%) got relieved of symptom after
discontinuation of antiplatelet agents or orophagryngealtreatment during initial episode of bleeding. In addition,
three recurred patients showed negative finding for
hemoptysis in follow-up chest CT again but revealed
chronic sinusitis with recurrent nasal polyps in sinus
examination. Therefore we assumed that these cases might
have not real episodes of hemoptysis.
In summary, we evaluated patients with hemoptysis who
showed no demonstrable cause of symptoms in chest CT.
We found the possible causes in some of patients through
the initial bronchoscopy and confirmed lung cancer in one
patient (0.4%). In addition, in 37.7% of all patients, the
cause of symptoms was identifiable using bronchoscopy,
careful history, and upper oropharyngeal evaluation. The
recurrence rate was significantly higher in patients with
positive bronchoscopy findings than in those with negative
bronchoscopy findings. Although about 20% of patients with
negative bronchoscopy findings developed recurrence, the
clinical course of these patients was benign and no cancer
developed during the follow-up period.Conflict of interest statement
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